U.S. markets close in 2 hours 23 minutes
  • S&P 500

    4,095.54
    -15.54 (-0.38%)
     
  • Dow 30

    33,690.27
    -200.75 (-0.59%)
     
  • Nasdaq

    11,864.33
    -23.12 (-0.19%)
     
  • Russell 2000

    1,956.58
    -1.13 (-0.06%)
     
  • Crude Oil

    76.59
    +2.48 (+3.35%)
     
  • Gold

    1,874.00
    +7.80 (+0.42%)
     
  • Silver

    22.18
    -0.06 (-0.26%)
     
  • EUR/USD

    1.0710
    -0.0021 (-0.19%)
     
  • 10-Yr Bond

    3.6320
    -0.0020 (-0.06%)
     
  • GBP/USD

    1.2005
    -0.0019 (-0.16%)
     
  • USD/JPY

    131.1600
    -1.4470 (-1.09%)
     
  • BTC-USD

    22,865.06
    -144.14 (-0.63%)
     
  • CMC Crypto 200

    526.38
    +0.43 (+0.08%)
     
  • FTSE 100

    7,864.71
    +28.00 (+0.36%)
     
  • Nikkei 225

    27,685.47
    -8.18 (-0.03%)
     

Should You Now Sell Fresenius Medical Care AG & Co. KGaA (FMS)?

Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund underperformed its benchmark index. Its Investor Class fund ARTLX returned -7.04%, Advisor Class fund APDLX posted a return of -7.07%, and Institutional Class fund APHLX returned -7.06% in the quarter, compared to a -5.62% return for the Russell 1000 Value Index. In addition, please check the fund’s top five holdings to know its best picks in 2022.

In the third-quarter letter, Artisan Partners discussed stocks like Fresenius Medical Care AG & Co. KGaA (NYSE:FMS). Headquartered in Bad Homburg, Germany, Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) provides dialysis care and related dialysis care services. On November 14, 2022, Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock closed at $15.37 per share. One-month return of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was 13.35% and its shares lost 53.37% of their value over the last 52 weeks. Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $9.02 billion.

Artisan Partners made the following comment about Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) in its Q3 2022 investor letter:

"We exited our position in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS), a vertically integrated provider of dialysis equipment and services. The company has experienced headwinds related to the pandemic, most notably due to the higher mortality rates found among dialysis patients. We anticipated the business would recover post-COVID and benefit from the secular growth of its end markets; however, the company has also suffered from cost inflation pressures and reimbursement challenges. Based on these factors, we chose to sell our remaining shares in favor of better opportunities."

10 Countries Accepting Indian Medical Degrees
10 Countries Accepting Indian Medical Degrees

Tyler Olson/Shutterstock.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 8 hedge fund portfolios held Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)  at the end of the second quarter, which was 10 in the previous quarter.

We discussed Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) in another article and shared the best European dividend stocks to buy in October. In addition, please check out our hedge fund investor letters Q3 2022 page for more investor letters from hedge funds and other leading investors.

 

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.